PROPEL

IMA Clinical Research Adds Devana Solutions’ PROPEL Clinical Trial Data Platform

January 10, 2022 by

Bringing the Clinical Trial Site to the Patient: IMA Clinical Research Adds Devana Solutions’ PROPEL Clinical Trial Data Platform

 

While 2021 certainly had its ups and downs, the Devana Solutions team is delighted to say we were able to end the year with a BANG! This past year we focused on accelerating clinical trials through the power of connectivity and data through our new PROPEL Enterprise technology. With the pandemic accelerating the shift to decentralized clinical trials, the PROPEL platform became an invaluable asset to our larger research organization clients. Devana PROPEL is leveraging the cloud to connect central research operations professionals with site-based clinicians and staff for real-time clinical trial collaboration. In short, Devana Solutions is bringing the clinical trial site to the patient. 

Today, Devana Solutions is pleased to announce IMA Clinical Research has made the commitment to adopt the most innovative site operations and analytics platform in the clinical trials industry, Devana PROPEL. “Partnering with Devana Solutions aligns with IMA Clinical Research’s centralization strategy initiated to improve efficiency within our network and accelerate study startup, supporting our mission of advancing the development of novel treatments to patients in need,” said IMA Group CEO & President, Mark Weinberger, Ph.D., MPH. 

With a rapidly growing network of traditional site locations, over 100 satellite sites and a database of over 300,000 patients, IMA Clinical Research represents the ideal client-profile to adopt Devana PROPEL Enterprise. “We are thrilled to welcome IMA Clinical Research onto our PROPEL platform,” commented Barry Lake, Devana Solutions’ CEO and Co-Founder. “They truly are a perfect fit for our technology which uses the power of the cloud to bring the expertise of clinical trials professionals into the diverse community site locations where IMA Clinical Research excels. Their broadly distributed site network allows millions of genetically, socially and racially diverse patient populations in urban centers and underserved locations to access clinical trials as a care option.” 

Patient access to clinical trials and research professionals leveraging advanced technology shouldn’t be limited by geography. They won’t, thanks to cloud-based platforms like Devana Solutions PROPEL and IMA Clinical Research. Stay tuned for a steady stream of new Devana Solutions client-partnership announcements in 2022! 

 

About Devana Solutions

Decentralized clinical trials and work-from-anywhere is now a reality. Devana Solutions innovative cloud platform supports real-time collaboration between central research operations professionals and decentralized clinicians serving patients in diverse communities. Devana even bridges the technology access and data divide by seamlessly and securely connecting decentralized researchers to other mission-critical clinical trials systems. From pipeline administration to rapid study startup automation. From document-sharing through the capture, display, analysis, and exchange of key trial performance metrics data from central research leaders to decentralized trial teams. From investigative site to CRO to trial sponsor, Devana Solutions is the answer. At Devana Solutions, we’re transforming the business of clinical trials. https://devanasolutions.com/ 

About IMA Clinical Research

IMA Clinical Research, a division of The IMA Group, is a physician-founded network of integrated clinical research sites specializing in Phase II-IV clinical trials in multiple therapeutic areas. IMA Clinical Research offers a flexible delivery model for site-based, hybrid and fully decentralized trials through its network of dedicated research clinics, a nationwide array of 100 satellite sites and a rapidly-growing database of over 300,000 patients.  We provide centralized processes for contracting, regulatory, training and patient recruitment ensuring rapid start-up, efficient enrollment and high-quality delivery across our network. For more information visit https://imaresearch.com/ or https://theimagroup.com/. 

 

IGNITE | IQ | PROPEL | Uncategorized

Announcing Our Clinical Research IO (CRIO) Integration is Complete!

October 19, 2020 by

CHAPEL HILL, NC (October 15, 2020) — Devana Solutions, LLC is pleased to announce the successful completion of their seamless integration with leading CTMS platform, Clinical Research IO (CRIO), to continue to help clinical research sites become more efficient by decreasing clinical trial cycle time to speed therapeutic advances to patients.

Devana Solutions’ novel IGNITE platform has added immense value to leading research organizations by providing a platform that streamlines and automates workflows, captures key timing metrics, and provides robust reporting and dashboarding capabilities during study startup and screening and enrollment. To continue to support these organizations, Devana has partnered with CRIO, sharing the same value and mission, to simplify and make the entire clinical trial process more efficient.

“Whenever Devana looks to launch a strategic partnership with another technology provider to benefit our customers, we look for a firm that is innovative and has deep roots in the research site sector,” stated Barry Lake, Devana Solutions’ CEO, “Clinical Research IO, under Raymond’s leadership, certainly checks both of these boxes.”

“At Clinical Research IO, we distinguish ourselves with a product that seamlessly addresses the challenges in clinical trials. Our collaboration with another industry trail blazer, Devana, is a partnership that will further increase clinical trial efficiency,” said CRIO’s Co-Founder, Raymond Nomizu. “A data driven approach enhances every site’s ability to make critical decisions and taking advantage of our technology allows sites to gather and analyze more data than ever before. We look forward to implementing this partnership with our growing list of mutual clients.”

With the integration now complete, the two companies’ mutual client-partners will benefit from an end-to-end business intelligence solution, providing transparency into clinical trial performance metrics for analysis and decision-making. The combined efficiencies that Devana IGNITE and CRIO provide will speed up the clinical trial process, help leadership to make more informed decisions and ultimately, advance therapies to patients faster and at a lower cost.

ABOUT DEVANA SOLUTIONS, LLC: 

Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce clinical trial cycle time and costs to speed the delivery of new therapies to patients. Devana Solutions offers three platforms, IGNITE, PROPEL and IQ for sponsors and CROs, to provide historical and real-time data capture, aggregation and display to drug development stakeholders. For more information call (877) DEVANA-2 or visit www.devanasolutions.com.

ABOUT CLINCIAL RESEARCH IO:

Clinical Research IO is the leading eSource solution for clinical research sites. Since its launch in September 2016, over 600 research sites have adopted the system. For more information, visit www.clinicalresearch.io.

1 2